SMTL ID : 8eli.1

Broadly neutralizing antibody VRC34-combo.1 in complex with HIV fusion peptide (residue 512-519)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.49 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ALA- VAL- GLY- ILE- GLY- ALA- VAL- PHE: Fusion peptide(Non-covalent)

ALA-VAL-GLY-ILE-GLY-ALA-VAL-PHE.1: 19 residues within 4Å: Chain A: E.32, M.91, S.92, S.93, Y.94, L.96 Chain B: T.30, G.31, A.33, W.50, N.52, H.54, D.57, T.58, F.59, Y.101, N.104, E.105, A.106 22 PLIP interactions: 16 interactions with chain B, 6 interactions with chain A Hydrophobic interactions: B:A.33, B:W.50, B:N.52, B:Y.101, B:A.106, A:E.32, A:Y.94, A:L.96 Hydrogen bonds: B:N.52, B:Y.101, B:Y.101, B:N.104, B:A.106, A:E.32, A:M.91, A:Y.94 Water bridges: B:S.55, B:Y.101, B:N.104, B:N.104, B:N.104, B:N.104

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Banach, B.B. et al., Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site. Nat Commun (2023)

Release Date

2023-09-27

Peptides

VRC34-combo.1 Fab Light chain: A
VRC34-combo.1 Fab Heavy chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

VRC34-combo.1 Fab Light chain

VRC34-combo.1 Fab Heavy chain

Related Entries With Identical Sequence